GTR 110039007
Bids Are Invited For Acquisition Of Medicine And Hospital Materials (54/2025)
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
110039007
Tendering Authority
Subscribe to view
Tender No
09/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Medicine And Hospital Materials (54/2025)
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
19-03-2026
Closed
Work Detail
Acebrophylline, Concentration: 10 Mg/Ml, Syrup - Unit: 100 Bottle, 00 Ml - Br0448839, Concentration: 5 Mg/Ml, Syrup. Unit: Bottle 120.00 Ml - Br0448838., Aciclovir:200 Mg. Unit: Tablet - Br0268370., Acyclovir:50 Mg/G, Usage:Cream. Unit: 10.00 G Tube - Br0268375., Acetylsalicylic Acid, Presentation: Buffered, Dosage: 325Mg. Unit: Tablet - Br0270548., 05/03/2026 - 13:33:38, 05/03/2026 - 13:34:33, 05/03/2026 - 13:35:04, Acetylsalicylic Acid:100 Mg. Unit: Tablet - Br0267502., Ascorbic Acid, Dosage:100 Mg/Ml, Type Of Use:Injectable - Ampoule 5.00 Ml -Br0271687, Folic Acid, 5 Mg. Unit: Tablet - Br0267503., Tranexamic Acid, Dosage:250 Mg. Unit: Tablet - Br0278338., 50 Mg/Ml, Injectable Solution. Unit: Ampoule 5.00 Ml - Br0327566., Essential Fatty Acids, Composition: (Capric, Caprylic And Linoleic Triglycerides), Components: Sunflower Oil. Unit: 200 Ml Bottle - Br0449688., Distilled Water, Physical Aspect: Double-Distilled, Sterile, Non-Pyrogenic. Unit: Ampoule 10.00 Ml - Br0315056., Non-Pyrogenic. Unit: Ampoule 20, Albendazole, 400 Mg. Unit: Tablet - Br0267506., 40 Mg/Ml, Use: Oral Suspension. Unit: Bottle 10.00 Ml - Br0267507., Sodium Alendronate, 70 Mg. Unit: Tablet - Br0269462., Allopurinol, 300 Mg. Unit: Tablet - Br0267509., Alprazolam, 1 Mg. Unit: Tablet - Br0271356., Alprazolam:2 Mg. Unit: Tablet - Br0284465., Ambroxol, Composition: Hydrochloride Salt, Concentration: 3 Mg/Ml, Syrup. Unit: Bottle 120.00 Ml - Br0446264., Concentration:6 Mg/Ml, Pharmaceutical Form:Syrup. Unit: Bottle 120.00 Ml - Br0446263., Amikacin Sulfate, Dosage:250 Mg/Ml, Indication:Injectable Solution. Unit: Ampoule 2.00 Ml - Br0268381., Dosage:50 Mg/Ml, Injectable Solution. Unit: Ampoule 2.00 Ml - Br0268383., Aminophylline, Dosage:100 Mg. Unit: Tablet - Br0267511., Dosage:24 Mg/Ml, :Injectable Solution. Unit: Ampoule 10.00 Ml - Br0292402., Amiodarone, Dosage:100Mg. Unit: Tablet - Br0271709., Dosage:200 Mg. Unit: Tablet - Br0267510., Dosage:50Mg/Ml, Indication:Injectable. Unit: Ampoule 3.00 Ml - Br0271710., Amitriptyline Hydrochloride, Dosage:25 Mg. Unit: Tablet - Br0267512., Dosage:75 Mg. Unit: Tablet - Br0276333., Amoxicillin, 500Mg. Unit: Capsule - Br0271089., Amoxilin, Concentration: 50Mg/Ml, Presentation: Powder For Oral Suspension - 150Ml Bottle - Br0271111, Active Ingredient: Associated With Potassium Clavulanate, Concentration: 50 Mg/Ml + 12.5 Mg/Ml, Pharmaceutical Form: Unit: 100 Ml Bottle - Br0448841, Concentration:500Mg + 125Mg. Unit: Tablet - Br0271217., Ampicillin, Dosage: 1 G, Type Of Use: Injectable. Unit: Ampoule Bottle - Br0268207., Amlodipine Besylate, Dosage: 10 Mg. Unit: Tablet - Br0268896., Dosage:5 Mg. Unit: Tablet - Br0272434., Aripiprazole, Concentration: 10 Mg. Unit: Tablets - Br0364780., Atenolol, Dosage:25 Mg. Unit: Tablet - Br0267516., Dosage:50 Mg. Unit: Tablet - Br0267517., Atropine Sulfate, Dosage:0, Use:Injectable Solution. Unit: Ampoule 1.00 Ml - Br0277934., Azithromycin, Dosage:40 Mg/Ml, Oral Suspension. Unit: Bottle 15.00 Ml - Br0268949., Dosage:500 Mg. Unit: Tablet - Br0267140., Beclomethasone Dipropionate, Presentation: Nasal Spray, Dosage: 50Mcg/Dose, Additional Features: Bottle. Unit: Bottle 200, 00 Doses - Br0267582., Presentation:Oral Spray, Dosage:250Mcg/Dose, 00 Doses - Br0267581., Benzylpenicillin, Presentation:Benzatine, Dosage:
Key Value
Tender Value
3,057,998 - BRL
Tender Documents
Global Tender Document
44dacd3f-fc70-4fa7-bc4e-dd4862e37fe8.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.